Driving Adoption of Digital Measures in Clinical Research and Development
The ActiGraph Digital Data Summit (ADDS) gathers digital health leaders to share insights, case studies, and best practices in wearable technology for clinical research. Since 2022, ADDS has earned praise for its scientific content and valuable networking opportunities—making it the perfect time to bring the summit to Europe and connect with the region’s top digital health experts.
We're excited to announce that ADDS Basel 2025 will take place on September 12, 2025 at the MC3 Main Conference Convention Center in Allschwil.
Be sure to mark your calendar and stay tuned for more details coming soon!
We will host a scientific poster session during ADDS Basel 2025 featuring original research that involves the use of wearable digital health technologies (DHTs). This is an exciting opportunity for students and researchers to share their work with the broader digital health community. We invite you to submit your abstract for consideration to be included in the poster session no later than Sunday, July 27. Applicants will be eligible to apply for a travel award based on scientific merit and financial need.
It's nice to have a conference that has a very specific focus, because we can dive much deeper into that and really get into the meat of the data. You can get into a much deeper understanding of the particular topic as well as some of the advancements in the field.
Ariel Dowling, PhD
Head of Sensing and Measurement | Takeda
It's a perfect thing when you can come to a conference, and you can meet people and immediately realize that you have things in common and can help each other; to meet other people who are really in different fields, but experiencing some of the same issues and develop potential collaborations across the board.
Johathan Soslow
Pediatric Cardiologist | Vanderbuilt University
An event like this brings talent that you normally are not exposed to, and as you see these presentations, you're shocked as to how much innovation is out there.
Peter Fernandes
CEO | Bellerophon Therapeutics
I think a lot of us do research in the technology and how we can apply it to our specific research interests or populations, but learning how to cross those boundaries between clinical populations is important.
Jennifer Schrack
Professor of Epidemiology and Medicine | Johns Hopkins Bloomberg School of Public Health
